Item 1.02 Termination of a Material Definitive Agreement.
On May 18, 2022, Mycotopia Therapies Inc. (the "Company") entered into an
Agreement and Plan of Merger (the "Agreement") whereby the Company was to merge
with a wholly owned subsidiary of PSLY.com. Simultaneously E.iVentures, Inc.
("E.i") was to merge with a separate wholly owned subsidiary of PSLY.com.
On February 16, 2023, the parties to the Agreement mutually agreed to terminate
the Agreement and release each other. The preceding description of the
termination is qualified in its entirety by reference to the Termination of
Agreement and Plan of Merger dated February 16, 2023, and provided herewith as
an Exhibit to this Current Report.
Item 7.01 Regulation FD Disclosure.
On February 21, 2023, the Company, PSLY.com and E.i Ventures issued a joint
press release announcing the termination of the Agreement and Plan of Merger,
the withdrawal of the PSLY.com's S-4 filing with the SEC and the withdrawal of
PSLY.com's Nasdaq application.
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS
Exhibit No. Description
10.1 Termination of Agreement and Plan of Merger
99.1 Press Release Announcing Termination of Agreement and Plan of
Merger
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses
MYCOTOPIA THERAPIES, INC. 